Christiane Hanke-Harloff is currently a Board member of InnoCore and Ascenion GmbH, a former Board member of Recipharm AB and also serves as an advisor for life science sector investors and biotech firms. Previously she held executive roles at Gilead Sciences, Gedeon Richter and other biotech companies, where she was responsible for organisational strategy and the expansion of international business units. She has a PhD in molecular biology from the Max Planck Institute of Biochemistry, Martinsried, Germany.